pharmacie et médicaments – Baisse du plafond de remise sur les génériques

This written question asks about the potential impact of lowering the rebate cap on generic medicines in France. It seeks clarification on the government's reasoning and expected consequences for the pharmaceutical market. The question concerns pharmaceutical companies, pharmacies, and potentially patients, as changes in rebate caps can affect drug pricing and availability.